Atlas Global Brands Inc
OTC:AGBIF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atlas Global Brands Inc
OTC:AGBIF
|
CA |
|
F
|
Firstfarms A/S
CSE:FFARMS
|
DK |
|
H
|
Holding Company ADMIE IPTO SA
ATHEX:ADMIE
|
GR |
|
Enfusion Inc
NYSE:ENFN
|
US |
|
Ellipsiz Ltd
SGX:BIX
|
SG |
Atlas Global Brands Inc
Atlas Global Brands, Inc. engages in the medical cannabis value chain, which includes cultivation, manufacture, marketing, distribution, and pharmacy. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2009-04-08. The firm is engaged in cannabis value chain business, which includes cultivation, manufacturing, scalability, marketing, distribution, and pharmacy. The firm serves across eight countries, which include Australia, Canada, Denmark, Germany, Israel, Norway, Spain, and the United Kingdom. The company also operates two fully accredited and licensed cannabis facilities, including one European Union-Goods Manufacturing Practices (EU-GMP) facility. The firm primarily operates in Canada and Israel.
Atlas Global Brands, Inc. engages in the medical cannabis value chain, which includes cultivation, manufacture, marketing, distribution, and pharmacy. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2009-04-08. The firm is engaged in cannabis value chain business, which includes cultivation, manufacturing, scalability, marketing, distribution, and pharmacy. The firm serves across eight countries, which include Australia, Canada, Denmark, Germany, Israel, Norway, Spain, and the United Kingdom. The company also operates two fully accredited and licensed cannabis facilities, including one European Union-Goods Manufacturing Practices (EU-GMP) facility. The firm primarily operates in Canada and Israel.
